A Non-interventional Retrospective Study of the Current Treatment Practice in European Haemophilia Care

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02049099

Enrollment

1658

Registered

2014-01-29

Start date

2014-03-31

Completion date

2015-09-30

Last updated

2016-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Haemophilia A, Haemophilia B

Brief summary

To describe the current treatment practice during 12 months for previously treated patients diagnosed with haemophilia A or haemophilia B.

Detailed description

The study population consists of patients with a diagnosis of ICD10: haemophilia A D66.9 or haemophilia B D67.9.

Interventions

None listed

Study design

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

MALE

Age

2 Years to No maximum

Healthy volunteers

Inclusion criteria

* Male patients with severe or moderate haemophilia A or haemophilia B. * Treatment with Factor VIII/Factor IX products initiated at least 24 months before inclusion in the study. * Informed consent is obtained from the patient or patient's legal representative (as applicable according to legal regulation).

Exclusion criteria

* Confirmed positive inhibitor test detected in the past 24 months.

Design outcomes

Primary

Measure	Time frame
Total dose (IU) issued of Factor VIII during a 12 month period	- 12 month to Day 0
Total dose (IU) issued of Factor IX during a 12 month period	- 12 month to Day 0

Countries

Belgium, France, Germany, Italy, Spain, Sweden, United Kingdom

Outcome results